Login

Financial Snapshot

Revenue
TTM
$72.35M
Gross Margin
TTM
81.52%
Net Income
TTM
-$45.34M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
47.47%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
-23.17M
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$32.40M

Stock Price

Loading...
Market Cap: $104.09 Million

About AVITA Medical Inc

AVITA Medical Inc (NASDAQ: RCEL) is a medical device and regenerative medicine company that commercializes cell-harvesting technology for skin restoration. The filing excerpts provided do not contain sufficient detail to describe its revenue model, segment breakdown, customer concentration, geographic mix, competitive position, or financial metrics with source-grounded specificity. Based solely on the excerpts available from the 10-K filed 2026-02-12 (accession 000119312526049031), no further factual claims about the business can be supported.

Source: SEC 10-K, filed 2026-02-12

Industry: Surgical & Medical Instruments & Apparatus Peers: Astria Therapeutics, Inc. Celcuity Inc DermTech, Inc. Icosavax, Inc. IPI Legacy Liquidation Co PepGen Inc Ovid Therapeutics Inc Oric Pharmaceuticals Inc Tenaya Therapeutics Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support